Insider Stock Trading History of Farrow Jeffrey S


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Farrow Jeffrey S since year 2005. The trader's CIK number is 1405253. At the time of this reporting, Farrow Jeffrey S is the Chief Financial Officer of Global Blood Therapeutics, Inc. . (stock ticker symbol GBT). See this page for all insider trading activities at Global Blood Therapeutics, Inc. .

Note that in the past Farrow Jeffrey S also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Farrow Jeffrey S since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-08-01 GBT Global Blood Therapeutics, Inc. Option Ex 3,062 .00 0
2015-05-01 HPTX Hyperion Therapeutics Inc Option Ex 120,777 4.98 601,469

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Farrow Jeffrey S (Chief Financial Officer of Global Blood Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.